Blood Platelet Market Is Predicted to See Lucrative Gains Over 2021-2026

The blood platelet market is poised to accrue considerable revenue growth owing to increasing adoption of blood transfusion procedures worldwide. Blood platelet plays an important role in human anatomy and its deficiency can lead to life-threatening situations. These platelets help in controlling or preventing blood loss. As per a report by the World Health Organization (WHO), nearly 51,400 hospitals from a total of 120 countries conduct blood transfusion operations, serving approximately 6 billion people.

A look at the recent research trends in the global blood platelet market reveals the identification of mechanisms behind the key cause of mortality and morbidity in COVID-19 patients by a team of Yale University researchers. A wide range of blood clots in both small and large blood vessels in the lungs and throughout numerous major organs in the body have connections, in turn worsening the outcomes for patients severely infected with COVID-19.

Get sample copy of this research report @

Platelets are the first defense against vascular damage in the human body. However, a lately published study in the journal “Blood” has demonstrated the triggering of platelet dysfunction and damage by the SARS-CoV-2 virus. Additional injury to the endothelial cells, the cells which line lymphatic vessels and blood, may further appear to be connected to severe illness and death, in turn contributing to worsening outcomes in COVID-19 patients, creating the need for maintaining blood platelet count among such patients.

Rising awareness regarding the increasing requirement for blood platelets in the human body is expected to drive Latin America blood platelet market outlook through the forthcoming years. The blood platelet market in Brazil had a valuation of more than USD 93 million in 2019.

Rising prevalence of infectious diseases such as dengue have led to initiation of numerous blood donation drives across the globe. In critical cases, blood platelet transfusion becomes a necessary option for treating such diseases. Presence of large geriatric population base across Northeastern Europe has led to a 12% increase in demand for blood transfusions. This could boost the number of blood banks in European nations over the forthcoming years.

Companies operating in the blood blood platelet market are taking part in multiple blood donation campaigns as well as blood supply services to fulfil the ever-growing need for healthy blood and blood components. Companies are focusing on developing new treatment options and drugs to enhance the presence of blood platelets. Currently, companies like America’s Blood Centers, American National Red Cross, Blood Centers of America, American Association of Blood Banks (AABB), Canadian Blood Services, Brazilian Red Cross, OneBlood and European Blood Alliance (EBA) are leading the industry landscape with their pioneering services.

Request for a Customization of this research report @

Partial Chapter of the Table of Content

Chapter 4   Blood Platelet Market, By Application

4.1    Key segment trends

4.2    Hemophilia

4.2.1    Market size, by region, 2015– 2026 (USD Million)

4.3    Thrombocytopenia

4.3.1    Market size, by region, 2015– 2026 (USD Million)

4.4    Perioperative indications

4.4.1    Market size, by region, 2015– 2026 (USD Million)

4.5    Platelet function disorders

4.5.1    Market size, by region, 2015– 2026 (USD Million)

4.6    Others

4.6.1    Market size, by region, 2015– 2026 (USD Million)

Chapter 5   Blood Platelet Market, By End-use

5.1    Key segment trends

5.2    Hospitals

5.2.1    Market size, by region, 2015 – 2026 (USD Million)

5.3    Ambulatory surgical centers

5.3.1    Market size, by region, 2015 – 2026 (USD Million)

5.4    Others

5.4.1    Market size, by region, 2015 – 2026 (USD Million)

Browse complete Table of Contents (ToC) of this research report @